TSMC hits back against Globalfoundries with countersuits in the US, Germany and Singapore. The headline grabbing dispute takes place as the Lion City attempts to lure more cases with legal reforms
The Jack Ma era has come to an end at the Chinese giant, leaving his successor to leverage the company’s data and services to establish a strong presence in the APAC region
In its third ever patent case, the country’s top court overturned its previous ruling that dependent claims automatically fall if their independent claims are found invalid
Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October
Southeast Asia is home to a thriving high-tech sector, but the patent systems in many of the region’s economies remain in their infancy.
The city-state’s patent office is touting six month turnaround – regardless of nationality – in a bid to spur local and overseas filings
A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them
At IPBC Southeast Asia, members of the region’s dynamic startup ecosystem heard that while IP may not yet be a critical threat to their business, it presents unique opportunities
The settlement deal ends litigation by the Singapore company’s ZiiLabs unit against Nvidia, and will net shareholders around $17.5 million
Operem is still working toward building a blockchain platform for patent trading, but its first product reflects demand for tools that enable open innovation efforts and trade secret protection
Intellectual Discovery has transferred auto and LED portfolios in recent weeks; both have spurred assertions in Delaware - increasingly the number one venue for US plaintiffs post-TC Heartland
Top legal experts in Singapore provide an exclusive insight into the country’s patent prosecution and litigation strategy for 2018
New report claims status of US, EU and UK as leading innovators under threat as they struggle to maximise return on R&D investment.